Sierra Leone

EUREKEALERT                                                                                                               Aug. 25, 2015
PITTSBURGH--The historic outbreak of Ebola virus disease in West Africa that began in March 2014 and has killed more than 11,000 people since, has raised new questions about the resilience of the virus and tested scientists' understanding of how to contain it. The latest discovery by a group of microbial risk-assessment and virology researchers suggests that the procedures for disposal of Ebola-contaminated liquid waste might underestimate the virus' ability to survive in wastewater.

Current epidemic response procedures from both the World Health Organization and the Centers for Disease Control and Prevention advise that after a period of days, Ebola-contaminated liquid can be disposed of directly into a sewage system without additional treatment.

However, new data recently published by researchers from the University of Pittsburgh, Drexel University, and the National Institutes of Health indicate that Ebola can survive in detectable concentrations in wastewater for at least a week or longer.

Read complete story.
http://www.eurekalert.org/pub_releases/2015-08/uop-pda082515.php

ASSOCIATED PRESS by CLARENCE ROY-MACAULAY    Aug. 24, 2015

MATENEH, Sierra Leone  — Health authorities in Sierra Leone released the country's last known Ebola patient from a hospital on Monday, a milestone that allows the nation to begin a 42-day countdown to being declared free of the virus that has killed nearly 4,000 people here.

Adama Sankoh, 40, centre, who contracted Ebola after her son died from the disease late last month stands with health officials the moment after she was discharge from Mateneh Ebola treatment center outskirt of Freetown, Sierra Leone, Monday, Aug. 24, 2015, Health authorities in Sierra Leone released the country's last known Ebola patient from the hospital on Monday, a milestone that allows the nation to begin a 42-day countdown to being declared free of the virus that has killed nearly 4,000 people here. (AP Photo/Alie Turay)

President Ernest Bai Koroma presented a certificate of discharge to Adama Sankoh, 40, who contracted Ebola after her son died from the disease late last month.

ASSOCIATED PRESS  by Carley Petesch              Aug. 23, 2015

DAKAR, Senegal --Lingering health problems afflicting many of the roughly 13,000 Ebola survivors have galvanized global and local health officials to find out how widespread the ailments are, and how to remedy them.

The World Health Organization calls it an emergency within an emergency. Many of the survivors have vision and hearing issues. Some others experience physical and emotional pains, fatigue and other problems. The medical community is negotiating uncharted waters as it tries to measure the scale of this problem that comes on the tail end of the biggest Ebola outbreak in history.

"If we can find out this kind of information, hopefully we can help other Ebola survivors in the future," Dr. Zan Yeong, an eye specialist involved in a study of health problems in survivors in Liberia, told The Associated Press.

About 7,500 people will enroll — 1,500 Ebola survivors and 6,000 of their close contacts — and will be monitored over a five-year period in the study launched by Partnership for Research on Ebola Vaccines in Liberia, or PREVAIL.

Read complete story.

MEDGADGET                                                                                   Aug. 20, 2015

BOSTON --At the 250^th National Meeting & Exposition of the American Chemical Society this week, researchers from MIT, Harvard Med School, and the FDA are showing off a new field test that can quickly screen people for Ebola, yellow fever, and dengue. While the researchers don’t claim their technique to be as accurate as PCR and ELISA, it is nevertheless an excellent tool in poor areas of the world where these diseases tend to thrive.

The test doesn’t require any water or electricity nor any complicated and expensive equipment. It works similar to pregnancy tests, providing a color readout that signals whether a disease is detected that is easily readable by just about anyone.